Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report.
Saved in:
| Title: | Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report. |
|---|---|
| Authors: | Schroeder T; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Chitadze G; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Dargvainiene J; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Martens T; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Gebauer N; Department of Haematology and Oncology, University Hospital Schleswig-Holstein Lübeck, University of Lübeck, Lübeck, Germany., Frimmel J; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Brüggemann M; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Valerius T; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Schub N; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Baldus CD; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Pott C; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Leypoldt F; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Stürner K; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany., Stölzel F; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Feb 16; Vol. 17, pp. 1749587. Date of Electronic Publication: 2026 Feb 16 (Print Publication: 2026). |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41777880 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Schroeder+T%22">Schroeder T</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Chitadze+G%22">Chitadze G</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Dargvainiene+J%22">Dargvainiene J</searchLink>; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Martens+T%22">Martens T</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Gebauer+N%22">Gebauer N</searchLink>; Department of Haematology and Oncology, University Hospital Schleswig-Holstein Lübeck, University of Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Frimmel+J%22">Frimmel J</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Brüggemann+M%22">Brüggemann M</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Valerius+T%22">Valerius T</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Schub+N%22">Schub N</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Baldus+CD%22">Baldus CD</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Pott+C%22">Pott C</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Leypoldt+F%22">Leypoldt F</searchLink>; Institute of Clinical Chemistry, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Stürner+K%22">Stürner K</searchLink>; Department of Neurology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Stölzel+F%22">Stölzel F</searchLink>; Department of Medicine II, Department of Haematology and Oncology, University Hospital Schleswig-Holstein Kiel, Kiel University, Kiel, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 Feb 16; Vol. 17, pp. 1749587. <i>Date of Electronic Publication: </i>2026 Feb 16 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Case Reports; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41777880 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2026.1749587 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1749587 Titles: – TitleFull: Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Schroeder T – PersonEntity: Name: NameFull: Chitadze G – PersonEntity: Name: NameFull: Dargvainiene J – PersonEntity: Name: NameFull: Martens T – PersonEntity: Name: NameFull: Gebauer N – PersonEntity: Name: NameFull: Frimmel J – PersonEntity: Name: NameFull: Brüggemann M – PersonEntity: Name: NameFull: Valerius T – PersonEntity: Name: NameFull: Schub N – PersonEntity: Name: NameFull: Baldus CD – PersonEntity: Name: NameFull: Pott C – PersonEntity: Name: NameFull: Leypoldt F – PersonEntity: Name: NameFull: Stürner K – PersonEntity: Name: NameFull: Stölzel F IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 02 Text: 2026 Feb 16 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1664-3224 Numbering: – Type: volume Value: 17 Titles: – TitleFull: Frontiers in immunology Type: main |
| ResultId | 1 |